The market for German startup HQ Imaging (°2015) is growing fast with the latest trend in radiology towards more standardization of MRI protocols.
It has become clear that having high-quality images is not only valuable for state-of-the-art research purposes. Also in routine clinical practice, it is crucial to use the right imaging protocol and the right scanner settings. This is especially the case when assessing multiple scans of patients over time in order to monitor disease progression. Patients do not always have their follow up scans on the same machine so large differences due to sub-optimal image quality make it extremely difficult for the radiologist to draw meaningful conclusions.
Since primary endpoints for clinical trials in neurological disorders are now often involving MRI data, also for pharmaceutical companies, harmonization of scanners is what can make or break a multi-center clinical trial.